Skip to main content
Clinical Trials/NCT03128970
NCT03128970
Completed
Not Applicable

Synchronizing Blastocyst at Hatching Stage in Frozen Embryo Transfer Cycles

Al-Yasmeen Fertility and Gynecology Center2 sites in 1 country742 target enrollmentApril 21, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Embryo Implantation
Sponsor
Al-Yasmeen Fertility and Gynecology Center
Enrollment
742
Locations
2
Primary Endpoint
Ongoing implantation rate
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The aim of the present study is to determine if implantation rate could be increased in women undergoing frozen embryo transfer cycles in case of adjusting their embryo development at hatching stage.

Registry
clinicaltrials.gov
Start Date
April 21, 2017
End Date
May 10, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Al-Yasmeen Fertility and Gynecology Center
Responsible Party
Principal Investigator
Principal Investigator

Yasmin Magdi

Dr

Al-Yasmeen Fertility and Gynecology Center

Eligibility Criteria

Inclusion Criteria

  • Patients who will agree to participate and assign an informed consent form
  • Only blastocyst transfer FET cycles
  • Patients undergoing FET after their 1st IVF or ICSI cycle with no pregnancy at the fresh transfer
  • Freeze-all cycles due to OHSS
  • Freeze-all cycles due to poor endometrium
  • Age 19-33 at the time of randomization.
  • Their frozen blastocysts are 3 or less grade of expansion.
  • Female with a ≥12 AFCs
  • Endometrial thickness ≥ 8mm at the time of ovulation
  • Women with their male partners will give only fresh semen

Exclusion Criteria

  • Cycles undergoing preimplantation genetic diagnosis.
  • Women who have previous two cycles of implantation failure at fresh transfer
  • Women who have previous two FET failed cycles
  • Any uterine pathology (myomas, adenomyosis, endocrinopathies, thrombophilia, chronic pathologies, acquired or congenital uterine abnormalities)
  • Patients with severe endometriosis
  • Presence of uni- or bilateral hydrosalpinx
  • Recurrent pregnancy loss.
  • Any medical condition that affect fertility.

Outcomes

Primary Outcomes

Ongoing implantation rate

Time Frame: 12 weeks

ultrasound detection of ongoing gestational sacs with heartbeats after 12 weeks of gestation per transferred embryos

Study Sites (2)

Loading locations...

Similar Trials